検索結果 - Deng H
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Match... 著者: Yang X, Deng H, Sun Y, Zhang Y, Lu Y, Xu G, Huang X
出版年 Journal of Hepatocellular Carcinoma (2023-02-01)全文の入手
論文
